Cargando…

Perfusion magnetic resonance imaging in the differentiation between glioma recurrence and pseudoprogression: a systematic review, meta-analysis and meta-regression

BACKGROUND: Tumor recurrence and pseudoprogression (PsP) have similar imaging manifestations in conventional magnetic resonance imaging (MRI), although the subsequent treatments are completely different. This study aimed to evaluate the value of perfusion-weighted imaging (PWI) in differentiating Ps...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Jun, Wang, Yulin, Wang, Yan, Xiao, Huafeng, Chen, Xinjing, Lei, Yifei, Feng, Zhebin, Ma, Xiaodong, Ma, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511424/ https://www.ncbi.nlm.nih.gov/pubmed/36185045 http://dx.doi.org/10.21037/qims-22-32

Ejemplares similares

The diagnostic performance of perfusion MRI for differentiating glioma recurrence from pseudoprogression: A meta-analysis
por: Wan, Bing, et al.
Publicado: (2017)

Meta-analysis of the diagnostic performance of diffusion magnetic resonance imaging with apparent diffusion coefficient measurements for differentiating glioma recurrence from pseudoprogression
por: Yu, Yang, et al.
Publicado: (2020)

Diagnostic accuracy of dynamic contrast-enhanced magnetic resonance imaging for distinguishing pseudoprogression from glioma recurrence: a meta-analysis
por: Qiu, Jun, et al.
Publicado: (2021)

The Value of Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in the Differentiation of Pseudoprogression and Recurrence of Intracranial Gliomas
por: Jing, Hui, et al.
Publicado: (2022)

Magnetic resonance spectroscopy outperforms perfusion in distinguishing between pseudoprogression and disease progression in patients with glioblastoma
por: El-Abtah, Mohamed E, et al.
Publicado: (2022)

Pseudoprogression in low-grade glioma
por: Slater, Jason M., et al.
Publicado: (2019)

Dynamic Susceptibility Perfusion Imaging for Differentiating Progressive Disease from Pseudoprogression in Diffuse Glioma Molecular Subtypes
por: Richter, Vivien, et al.
Publicado: (2021)

Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastoma
por: Elshafeey, Nabil, et al.
Publicado: (2019)

Radiomics: The New Promise for Differentiating Progression, Recurrence, Pseudoprogression, and Radionecrosis in Glioma and Glioblastoma Multiforme
por: Alizadeh, Mohammadreza, et al.
Publicado: (2023)

Multimodal MRI-Based Radiomic Nomogram for the Early Differentiation of Recurrence and Pseudoprogression of High-Grade Glioma
por: Jing, Hui, et al.
Publicado: (2022)

Incidence of Tumour Progression and Pseudoprogression in High-Grade Gliomas: a Systematic Review and Meta-Analysis
por: Abbasi, Abdul W., et al.
Publicado: (2017)

Discriminators of pseudoprogression and true progression in high-grade gliomas: A systematic review and meta-analysis
por: Taylor, Chris, et al.
Publicado: (2022)

Retrospective examination of pseudoprogression in IDH mutant gliomas
por: Wetzel, Ethan A, et al.
Publicado: (2023)

Radiation Necrosis, Pseudoprogression, Pseudoresponse, and Tumor Recurrence: Imaging Challenges for the Evaluation of Treated Gliomas
por: Zikou, Anastasia, et al.
Publicado: (2018)

Neutrophil–lymphocyte ratio dynamics are useful for distinguishing between recurrence and pseudoprogression in high-grade gliomas
por: Huang, Yong, et al.
Publicado: (2019)

Advanced Imaging Techniques for Differentiating Pseudoprogression and Tumor Recurrence After Immunotherapy for Glioblastoma
por: Li, Yan, et al.
Publicado: (2021)

Diagnostic accuracy of glioma pseudoprogression identification with positron emission tomography imaging: a systematic review and meta-analysis
por: Ouyang, Zhi-Qiang, et al.
Publicado: (2023)

A systematic review and meta-analysis on the differentiation of glioma grade and mutational status by use of perfusion-based magnetic resonance imaging
por: van Santwijk, Lusien, et al.
Publicado: (2022)

The value of MGMT promote methylation and IDH-1 mutation on diagnosis of pseudoprogression in patients with high-grade glioma: A meta-analysis
por: Zhou, Min, et al.
Publicado: (2019)

RADI-43. ARTERIAL SPIN LABELING PERFUSION MR IMAGING FOR DIFFERENTIATION BETWEEN TUMOR RECURRENCE AND PSEUDOPROGRESSION IN INTRACRANIAL METASTASES FOLLOWING STEREOTACTIC RADIOSURGERY
por: Villanueva-Meyer, Javier, et al.
Publicado: (2019)

The Diagnosis and Treatment of Pseudoprogression, Radiation Necrosis and Brain Tumor Recurrence
por: Parvez, Kashif, et al.
Publicado: (2014)

Value of DWI Combined with Magnetic Resonance Spectroscopy in the Differential Diagnosis between Recurrent Glioma and Radiation Injury: A Meta-Analysis
por: Li, Hongyi, et al.
Publicado: (2022)

Multiple oligodendroglioma with pseudoprogression
por: Matsuyama, Junko
Publicado: (2012)

Pseudoprogression of brain tumors
por: Thust, Stefanie C., et al.
Publicado: (2018)

Pseudoprogression and Immunotherapy Phenomena
por: Waxman, Elizabeth S., et al.
Publicado: (2020)

Reevaluating the imaging definition of tumor progression: perfusion MRI quantifies recurrent glioblastoma tumor fraction, pseudoprogression, and radiation necrosis to predict survival
por: Hu, Leland S., et al.
Publicado: (2012)

Magnetic resonance analysis of malignant transformation in recurrent glioma
por: Jalbert, Llewellyn E., et al.
Publicado: (2016)

The Utility of Diffusion and Perfusion Magnetic Resonance Imaging in Target Delineation of High-Grade Gliomas
por: Fei, Qian, et al.
Publicado: (2020)

FET PET Radiomics for Differentiating Pseudoprogression from Early Tumor Progression in Glioma Patients Post-Chemoradiation
por: Lohmann, Philipp, et al.
Publicado: (2020)

Recent Application of Advanced MR Imaging to Predict Pseudoprogression in High-grade Glioma Patients
por: YOO, Roh-EUL, et al.
Publicado: (2015)

Radiomics for pseudoprogression prediction in high grade gliomas: added value of MR contrast agent
por: Mammadov, Orkhan, et al.
Publicado: (2022)

Analysis of pseudoprogression after proton or photon therapy of 99 patients with low grade and anaplastic glioma()
por: Bronk, Julianna K., et al.
Publicado: (2018)

Incidence of Immune-Mediated Pseudoprogression of Lymphoma Treated with Immune Checkpoint Inhibitors: Systematic Review and Meta-Analysis
por: Lee, Amy Junghyun, et al.
Publicado: (2021)

5-Aminolevulinic Acid False-Positive Rates in Newly Diagnosed and Recurrent Glioblastoma: Do Pseudoprogression and Radionecrosis Play a Role? A Meta-Analysis
por: Ricciardi, Luca, et al.
Publicado: (2022)

Evaluation of perfusion MRI value for tumor progression assessment after glioma radiotherapy: A systematic review and meta-analysis
por: Wang, Longlong, et al.
Publicado: (2020)

Pseudoprogression manifesting as recurrent ascites with anti-PD-1 immunotherapy in urothelial bladder cancer
por: Sweis, Randy F., et al.
Publicado: (2018)

Pseudoprogression as an adverse event of glioblastoma therapy
por: Balaña, Carmen, et al.
Publicado: (2017)

Pseudoprogression with Neoadjuvant Immunotherapy for Cutaneous Melanoma
por: Garcia, Diogo, et al.
Publicado: (2021)

Defining Treatment‐Related Adverse Effects in Patients with Glioma: Distinctive Features of Pseudoprogression and Treatment‐Induced Necrosis
por: Winter, Sebastian F., et al.
Publicado: (2020)

Blood Biomarkers of Glioma in Response Assessment Including Pseudoprogression and Other Treatment Effects: A Systematic Review
por: Raza, Istafa J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d2m9mp87d5bjeakjq3doepfdql